Heme Oxygenase 1‐Targeted Hybrid Nanoparticle for Chemo‐ and Immuno‐Combination Therapy in Acute Myelogenous Leukemia-Reference-Cited by-同舟云学术

Heme Oxygenase 1‐Targeted Hybrid Nanoparticle for Chemo‐ and Immuno‐Combination Therapy in Acute Myelogenous Leukemia

Published:2020-06-03 Issue:13 Volume:7 Page:2000487
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Yong Seok‐Beom¹,Kim Jaehyun¹^ORCID,Chung Jee Young¹,Ra Sehee¹,kim Seong Su¹,Kim Yong‐Hee¹

Affiliation:

1. Department of BioengineeringInstitute for Bioengineering and Biopharmaceutical ResearchBK 21 Plus Future Biopharmaceutical Human Resources Training and Research TeamHanyang University Seoul 133‐791 Republic of Korea

Funder

National Research Foundation of Korea

Ministry of Health and Welfare

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202000487

Reference48 articles.

1. Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level

2. How I treat acute myeloid leukemia

3. The future of immune checkpoint therapy

4. Checkpoint blocking antibodies in cancer immunotherapy

5. Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies;Cancer Communications;2024-07-28

2. Advanced nanotherapeutics inspired by the abnormal microenvironment of leukemia;Nano Research;2024-07-17

3. Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia;Small;2024-06-27

4. Hybrid multifunctional nanomaterials for cancer diagnostics and therapeutics;Functionalized Nanomaterials for Cancer Research;2024

5. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation;Molecular Cancer;2023-10-09